AAAAAA

   
Results: 1-25 | 26-43
Results: 1-25/43
NATRIURETIC PEPTIDES IN DETECTION OF HEART-FAILURE
Authors: DICKSTEIN K
Citation: K. Dickstein, NATRIURETIC PEPTIDES IN DETECTION OF HEART-FAILURE, Lancet, 351(9095), 1998, pp. 4-4
CARDIAC TROPONIN-I AND TROPONIN-T IN PATIENTS WITH SUSPECTED ACUTE CORONARY SYNDROME - A COMPARATIVE-STUDY IN A ROUTINE SETTING
Authors: HETLAND O DICKSTEIN K
Citation: O. Hetland et K. Dickstein, CARDIAC TROPONIN-I AND TROPONIN-T IN PATIENTS WITH SUSPECTED ACUTE CORONARY SYNDROME - A COMPARATIVE-STUDY IN A ROUTINE SETTING, Clinical chemistry, 44(7), 1998, pp. 1430-1436
CARDIAC TROPONIN-T BY ELECSYS SYSTEM AND A RAPID ELISA - ANALYTICAL SENSITIVITY IN RELATION TO THE TROPT (CARDIACT) BEDSIDE TEST
Authors: HETLAND O DICKSTEIN K
Citation: O. Hetland et K. Dickstein, CARDIAC TROPONIN-T BY ELECSYS SYSTEM AND A RAPID ELISA - ANALYTICAL SENSITIVITY IN RELATION TO THE TROPT (CARDIACT) BEDSIDE TEST, Clinical chemistry, 44(6), 1998, pp. 1348-1350
PLASMA BNP CAN RELIABLY EXCLUDE THE PRESENCE OF SIGNIFICANT LEFT-VENTRICULAR SYSTOLIC DYSFUNCTION (LVSD) IN PATIENTS SUSPECTED OF HAVING HEART-FAILURE OR ASYMPTOMATIC LVD (ASLVD)
Authors: HANNAH AH MURDOCH DR FOLLATH F TAVAZZI L RAY S DICKSTEIN K MORTON IJ MCDONAGH T DARGIE HJ
Citation: Ah. Hannah et al., PLASMA BNP CAN RELIABLY EXCLUDE THE PRESENCE OF SIGNIFICANT LEFT-VENTRICULAR SYSTOLIC DYSFUNCTION (LVSD) IN PATIENTS SUSPECTED OF HAVING HEART-FAILURE OR ASYMPTOMATIC LVD (ASLVD), Circulation, 98(17), 1998, pp. 3992-3992
DRUG SELECTION FOR OPTIMAL TREATMENT OF HYPERTENSION IN THE ELDERLY
Authors: SHAMMAS E DICKSTEIN K
Citation: E. Shammas et K. Dickstein, DRUG SELECTION FOR OPTIMAL TREATMENT OF HYPERTENSION IN THE ELDERLY, Drugs & aging, 11(1), 1997, pp. 19-26
THE HEMODYNAMIC AND NEUROHUMORAL EFFECTS OF MOXONIDINE, A SYMPATHETICINHIBITOR, IN CONGESTIVE-HEART-FAILURE
Authors: DICKSTEIN K KOPP U MANHENKE C AARSLAND T WAAGSTEIN F MOBINI R MCNAY J
Citation: K. Dickstein et al., THE HEMODYNAMIC AND NEUROHUMORAL EFFECTS OF MOXONIDINE, A SYMPATHETICINHIBITOR, IN CONGESTIVE-HEART-FAILURE, Journal of the American College of Cardiology, 29(2), 1997, pp. 7275-7275
MOXONIDINE, A CENTRALLY ACTING SYMPATHETIC INHIBITOR, CAUSES SUSTAINED REDUCTION OF PLASMA NOREPINEPHRINE IN HEART-FAILURE PATIENTS
Authors: SWEDBERG K WAAGSTEIN F DICKSTEIN K WILTSE C MCNAY J
Citation: K. Swedberg et al., MOXONIDINE, A CENTRALLY ACTING SYMPATHETIC INHIBITOR, CAUSES SUSTAINED REDUCTION OF PLASMA NOREPINEPHRINE IN HEART-FAILURE PATIENTS, Journal of the American College of Cardiology, 29(2), 1997, pp. 7625-7625
COMPARISON OF MAXIMAL VS SUBMAXIMAL EXERCISE PROTOCOLS - THE REPRODUCIBILITY OF THE NEUROHUMORAL RESPONSE IN PATIENTS WITH HEART-FAILURE
Authors: DICKSTEIN K AARSLAND T CHANG P
Citation: K. Dickstein et al., COMPARISON OF MAXIMAL VS SUBMAXIMAL EXERCISE PROTOCOLS - THE REPRODUCIBILITY OF THE NEUROHUMORAL RESPONSE IN PATIENTS WITH HEART-FAILURE, Journal of the American College of Cardiology, 29(2), 1997, pp. 98158-98158
EFFECTS OF EXERCISE TRAINING ON MAXIMAL AND SUBMAXIMAL ENDURANCE CAPACITY IN MEN WITH CONGESTIVE-HEART-FAILURE
Authors: LARSEN AI AARSLAND T KRISTIANSEN M HAUGLAND A DICKSTEIN K
Citation: Ai. Larsen et al., EFFECTS OF EXERCISE TRAINING ON MAXIMAL AND SUBMAXIMAL ENDURANCE CAPACITY IN MEN WITH CONGESTIVE-HEART-FAILURE, Journal of the American College of Cardiology, 29(2), 1997, pp. 98159-98159
MOXONIDINE IMPROVES HEART-RATE-VARIABILITY IN PATIENTS WITH HEART-FAILURE
Authors: JUULMOLLER S SWEDBERG K DICKSTEIN K MCNAY J
Citation: S. Juulmoller et al., MOXONIDINE IMPROVES HEART-RATE-VARIABILITY IN PATIENTS WITH HEART-FAILURE, Journal of the American College of Cardiology, 29(2), 1997, pp. 99656-99656
MARKERS OF COAGULATION IN ADMISSION BLOOD-SAMPLES OF PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION
Authors: HETLAND O DICKSTEIN K NILSEN DWT
Citation: O. Hetland et al., MARKERS OF COAGULATION IN ADMISSION BLOOD-SAMPLES OF PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION, Thrombosis and haemostasis, 1997, pp. 2140-2140
THE ROLE OF OBJECTIVE HEALTH INDICATORS AND NEUROTICISM IN PERCEIVED HEALTH AND PSYCHOLOGICAL WELL-BEING AMONG PATIENTS WITH CHRONIC HEART-FAILURE
Authors: MURBERG TA BRU E SVEBAK S AARSLAND T DICKSTEIN K
Citation: Ta. Murberg et al., THE ROLE OF OBJECTIVE HEALTH INDICATORS AND NEUROTICISM IN PERCEIVED HEALTH AND PSYCHOLOGICAL WELL-BEING AMONG PATIENTS WITH CHRONIC HEART-FAILURE, Personality and individual differences, 22(6), 1997, pp. 867-875
PLASMA BRAIN NATRIURETIC PEPTIDE AS AN INDICATOR OF LEFT-VENTRICULAR SYSTOLIC FUNCTION AND LONG-TERM SURVIVAL AFTER ACUTE MYOCARDIAL-INFARCTION - RESPONSE
Authors: OMLAND T LIE RT DICKSTEIN K
Citation: T. Omland et al., PLASMA BRAIN NATRIURETIC PEPTIDE AS AN INDICATOR OF LEFT-VENTRICULAR SYSTOLIC FUNCTION AND LONG-TERM SURVIVAL AFTER ACUTE MYOCARDIAL-INFARCTION - RESPONSE, Circulation, 95(2), 1997, pp. 538-539
COMPARISON OF THE DEGREE OF HEMODYNAMIC TOLERANCE DURING INTRAVENOUS-INFUSION OF NITROGLYCERIN VERSUS NICORANDIL IN PATIENTS WITH CONGESTIVE-HEART-FAILURE
Authors: LARSEN AI GORANSSON L AARSLAND T TAMBY JF DICKSTEIN K
Citation: Ai. Larsen et al., COMPARISON OF THE DEGREE OF HEMODYNAMIC TOLERANCE DURING INTRAVENOUS-INFUSION OF NITROGLYCERIN VERSUS NICORANDIL IN PATIENTS WITH CONGESTIVE-HEART-FAILURE, The American heart journal, 134(3), 1997, pp. 435-441
CARDIAC MARKERS IN THE EARLY HOURS OF ACUTE MYOCARDIAL-INFARCTION - CLINICAL-PERFORMANCE OF CREATINE-KINASE, CREATINE-KINASE MB ISOENZYME (ACTIVITY AND MASS CONCENTRATION), CREATINE-KINASE MM AND MB SUBFORM RATIOS, MYOGLOBIN AND CARDIAC TROPONIN-T
Authors: HETLAND O DICKSTEIN K
Citation: O. Hetland et K. Dickstein, CARDIAC MARKERS IN THE EARLY HOURS OF ACUTE MYOCARDIAL-INFARCTION - CLINICAL-PERFORMANCE OF CREATINE-KINASE, CREATINE-KINASE MB ISOENZYME (ACTIVITY AND MASS CONCENTRATION), CREATINE-KINASE MM AND MB SUBFORM RATIOS, MYOGLOBIN AND CARDIAC TROPONIN-T, Scandinavian journal of clinical & laboratory investigation, 56(8), 1996, pp. 701-713
NOVEL DRUGS AND CURRENT THERAPEUTIC APPROACHES IN THE TREATMENT OF HEART-FAILURE
Authors: BONARJEE VVS DICKSTEIN K
Citation: Vvs. Bonarjee et K. Dickstein, NOVEL DRUGS AND CURRENT THERAPEUTIC APPROACHES IN THE TREATMENT OF HEART-FAILURE, Drugs, 51(3), 1996, pp. 347-358
N-TERMINAL PROBRAIN NATRIURETIC PEPTIDE A NEW MARKER OF CARDIAC-FUNCTION AND PROGNOSIS
Authors: HALL C LANGVIK TA AARSLAND T DICKSTEIN K
Citation: C. Hall et al., N-TERMINAL PROBRAIN NATRIURETIC PEPTIDE A NEW MARKER OF CARDIAC-FUNCTION AND PROGNOSIS, Circulation, 94(8), 1996, pp. 1488-1488
THE RANDOMIZED ANGIOTENSIN RECEPTOR ANTAGONIST - ACE-INHIBITOR STUDY (RAAS) - PILOT-STUDY
Authors: PITT B DICKSTEIN K BENEDICT CR PACHER R WILLENHEIMER R MURALI S DUNLAY MC CHANG PI GROSSMAN W
Citation: B. Pitt et al., THE RANDOMIZED ANGIOTENSIN RECEPTOR ANTAGONIST - ACE-INHIBITOR STUDY (RAAS) - PILOT-STUDY, Circulation, 94(8), 1996, pp. 2497-2497
PLASMA BRAIN NATRIURETIC PEPTIDE AS AN INDICATOR OF LEFT-VENTRICULAR SYSTOLIC FUNCTION AND LONG-TERM SURVIVAL AFTER ACUTE MYOCARDIAL-INFARCTION - COMPARISON WITH PLASMA ATRIAL-NATRIURETIC-PEPTIDE AND N-TERMINAL PROATRIAL NATRIURETIC PEPTIDE
Authors: OMLAND T AAKVAAG A BONARJEE VVS CAIDAHL K LIE RT NILSEN DWT SUNDSFJORD JA DICKSTEIN K
Citation: T. Omland et al., PLASMA BRAIN NATRIURETIC PEPTIDE AS AN INDICATOR OF LEFT-VENTRICULAR SYSTOLIC FUNCTION AND LONG-TERM SURVIVAL AFTER ACUTE MYOCARDIAL-INFARCTION - COMPARISON WITH PLASMA ATRIAL-NATRIURETIC-PEPTIDE AND N-TERMINAL PROATRIAL NATRIURETIC PEPTIDE, Circulation, 93(11), 1996, pp. 1963-1969
MOEXIPRIL AS ADD-ON THERAPY TO HYDROCHLOROTHIAZIDE IN MODERATE TO SEVERE HYPERTENSION
Authors: STIMPEL M KOCH B DICKSTEIN K
Citation: M. Stimpel et al., MOEXIPRIL AS ADD-ON THERAPY TO HYDROCHLOROTHIAZIDE IN MODERATE TO SEVERE HYPERTENSION, Cardiology, 87(4), 1996, pp. 313-318
COMPARISON OF THE EFFECTS OF AQUEOUS AND GELLAN OPHTHALMIC TIMOLOL ONPEAK EXERCISE PERFORMANCE IN MIDDLE-AGED MEN
Authors: DICKSTEIN K AARSLAND T
Citation: K. Dickstein et T. Aarsland, COMPARISON OF THE EFFECTS OF AQUEOUS AND GELLAN OPHTHALMIC TIMOLOL ONPEAK EXERCISE PERFORMANCE IN MIDDLE-AGED MEN, American journal of ophthalmology, 121(4), 1996, pp. 367-371
COMPARISON OF THE EFFECTS OF LOSARTAN AND ENALAPRIL ON CLINICAL STATUS AND EXERCISE PERFORMANCE IN PATIENTS WITH MODERATE OR SEVERE CHRONICHEART-FAILURE
Authors: DICKSTEIN K CHANG P WILLENHEIMER R HAUNSO S REMES J HALL C KJEKSHUS J
Citation: K. Dickstein et al., COMPARISON OF THE EFFECTS OF LOSARTAN AND ENALAPRIL ON CLINICAL STATUS AND EXERCISE PERFORMANCE IN PATIENTS WITH MODERATE OR SEVERE CHRONICHEART-FAILURE, Journal of the American College of Cardiology, 26(2), 1995, pp. 438-445
PLASMA N-TERMINAL ATRIAL-NATRIURETIC-FACTOR IS PREDICTIVE OF MORTALITY IN PATIENTS WITH CONGESTIVE-HEART-FAILURE
Authors: DICKSTEIN K AARSLAND D HALL C
Citation: K. Dickstein et al., PLASMA N-TERMINAL ATRIAL-NATRIURETIC-FACTOR IS PREDICTIVE OF MORTALITY IN PATIENTS WITH CONGESTIVE-HEART-FAILURE, Circulation, 92(8), 1995, pp. 2618-2618
LOSARTAN IN HEART-FAILURE - HEMODYNAMIC-EFFECTS AND TOLERABILITY
Authors: CROZIER I IKRAM H AWAN N CLELAND J STEPHEN N DICKSTEIN K FREY M YOUNG J KLINGER G MAKRIS L RUCINSKA E
Citation: I. Crozier et al., LOSARTAN IN HEART-FAILURE - HEMODYNAMIC-EFFECTS AND TOLERABILITY, Circulation, 91(3), 1995, pp. 691-697
PLASMA ENDOTHELIN AS AN INDEPENDENT PREDICTOR OF MORTALITY - REPLY
Authors: OMLAND T AAKVAAG A DICKSTEIN K LIE RT AARSLAND T
Citation: T. Omland et al., PLASMA ENDOTHELIN AS AN INDEPENDENT PREDICTOR OF MORTALITY - REPLY, Circulation, 91(3), 1995, pp. 910-910
Risultati: 1-25 | 26-43